期刊文献+

胃癌组织中成纤维细胞生长因子19和成纤维细胞生长因子受体4的表达及临床意义 被引量:6

Expressions of fibroblast growth factor 19 and fibroblast growth factor receptor 4 in gastric cancer and their significance
下载PDF
导出
摘要 目的研究成纤维细胞生长因子19(FGF19)和成纤维细胞生长因子受体4(FGFR4)在胃癌组织中的表达及临床意义。方法应用免疫组织化学法检测该院2011~2014年50例胃癌术后病理标本中FGF19和FGFR4的表达。结果与癌旁正常胃组织比较,FGF19和FGFR4在胃癌组织中明显表达(P〈0.01)。胃癌组织中FGF19和FGFR4的表达与淋巴结转移以及病理分期呈正相关,并且胃癌组织中FGF19和FGFR4的表达也有显著相关性。结论 FGF19和FGFR4的表达强度与胃癌淋巴结转移以及病理分期密切相关,可作为判断胃癌预后的指标。 【Objective】 To explore the expressions of fibroblast growth factor 19(FGF19) and fibroblast growth factor receptor 4(FGFR4) in gastric cancer and normal gastric tissue and their relationship. 【Methods】Immunohistochemical method was used to detect the FGF19 and FGFR4 protein expressions in 50 postoperative pathological samples of gastric cancer patients in our hospital from 2011 to 2014. 【Results】 The expressions of FGF19 and FGFR4 were higher in the gastric cancer than in the normal gastric tissue beside gastric cancer(P 〈0.01). There were positive linear relationships between expressions of FGF19 and FGFR4 and both lymph node metastasis and pathological stage in gastric cancer. The expressions of FGF19 and FGFR4 were in a positive linear relationship in this disease.【Conclusions】 The expressions of FGF19 and FGFR4 are associated with lymphatic metastasis and pathological stage in gastric cancer, which suggests that their expressions may be the prognostic factors for gastric tumor.
出处 《中国现代医学杂志》 CAS 北大核心 2015年第26期55-59,共5页 China Journal of Modern Medicine
关键词 成纤维细胞生长因子19 成纤维细胞生长因子受体4 胃癌 fibroblast growth factor 19 fibroblast growth factor receptor 4 gastric cancer
  • 相关文献

参考文献16

  • 1JEMAL A,SIEGEL R,XU J,et al.Cancer statistics,2010[J].A Cancer Joumal for Clinicians,2010,60(5):277-300. 被引量:1
  • 2ESWARAKUMAR VP,LAX I,SCHLESSINGER J.Cellular sig- naling by fibroblast growth factor receptors[J].Cytokine Growth Factor Reviews,2005,16(2):139-149. 被引量:1
  • 3TENHAGEN M,VAN DIEST PJ,IVANOVA IA,et al.Fibroblast growth factor receptors in breast cancer:expression,downstream effects,and possible drug targets[J].Endocrine-related Cancer,2012,19(4):115-129. 被引量:1
  • 4SAWEY ET,CHANRION M,CAI C,et al.Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by oncogenomic screening[J].Cancer Cell,2011,19(3):347-358. 被引量:1
  • 5ROIDL A,FOO P,WONG W,et al.The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells[J].Oncogene,2010,29(10):1543-1552. 被引量:1
  • 6SOSLOW RA,DANNENBERG AJ,RUSH D,et al.Cox-2 is expressed in human pulmonary,colonic,and mammary tumors[J].Cancer,2000,89(12):2637-2645. 被引量:1
  • 7MATAKIDOU A,GALTA R,RUDD MF,et al.Further observa- tions on relationship between the FGFR4 Gly388 Arg polymor- phism and lung cancer prognosis[J].British Joumal of Cancer,2007,96(12):1904-1907. 被引量:1
  • 8MIURA Sf MITSUHASHI N,SHIMIZU H,et al.Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma[J].Bmc Cancer,2012,12:56. 被引量:1
  • 9DRAFAHL KA,MCANDREW CW,MEYER AN,et al.The re- ceptor tyrosine kinase FGFR4 negatively regulates NF-kappa B signaling[J].PIos One,2010,5(12):doi:10.1371/Joumai.pone.0014412. 被引量:1
  • 10ORNITZ DM,ITOH N.Fibroblast growth factors[J].Genome Bi- ology,2001,2(3):3005. 被引量:1

二级参考文献35

  • 1Shigeo T, Mitsutaka S, Yukari M, et al. Identification of a novel ahernative splicing of human FGF receptor 4:soluble-form splice variant expressed in human gastrointestinal epithelial cells [J]. Biochemi Biophy Res Communications, 2000, 267(2) :658-662. 被引量:1
  • 2Morimoto Y, Ozaki T, Ouchida M, et al. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in highgrade soft tissue sarcoma [J]. Cancer, 2003,98 (10) : 2245 -2250. 被引量:1
  • 3Streit S, Mestel D S, Schmidt M, et al. FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients [J]. Br J Cancer,2006,94 (12), 1879-1586. 被引量:1
  • 4Spinola M, Leoni V, Pignatiello C, et al. Functional FGFR4 Gly388 Arg polymorphism predicts prognosis in lung adenocarcinoma patients [J]. J Clin Oncol, 2005,23(29):7307-7311. 被引量:1
  • 5Streit S, Bange J, Fichtner A, et al. Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma [J]. Int J Cancer,2004,111(2) :213-217. 被引量:1
  • 6da Costa Andrade V C, Parise O Jr, Hors C P, et al. The fibroblast growth factor receptor4(FGFR4)Arg388 allele correlates with survival in head and neck squamous cell carcinoma [J ]. Exp Mol Pathol, 2007, 82( 1 ) : 53-57. 被引量:1
  • 7Powers C J, McLeskey S W, Wellstein A. Fibroblast growth factors,their receptors and signaling [J]. Endocrine Related Cancer, 2000,7(3) : 165-197. 被引量:1
  • 8Burke D, Wilkes D, Blundell T L, et al. Fibroblast growth factor receptors: lessons from the genes [J]. Trends Biochem Sci, 1998,23 ( 1 ) : 59-62. 被引量:1
  • 9Reiland J, Kempf D, Roy M, et al. FGF2 binding, signaling,and angiogenesis are modulated by heparanase in metastatic melanoma cells [J]. Neoplasia, 2006,8 (7) :596-606. 被引量:1
  • 10Ferrara N, Gerber H P, LeCouter J. The biology of VEGF and its receptors [J]. Nat Med, 2003, 9(6) : 669-676. 被引量:1

共引文献9

同被引文献40

引证文献6

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部